Cite
HARVARD Citation
Hollander, P. et al. (2019). Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin. Current medical research and opinion. pp. 1335-1343. [Online].